June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, Clitoria ternatea (Sangu Poo) was noted for its potential roles in health and skincare, with lab tests showing antioxidant, antimicrobial, liver-protective, and cancer-related activities; however, human trial evidence is lacking, impacting consistent quality and progress.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study reviews the traditional and emerging medicinal uses of Clitoria ternatea Linn., highlighting its extensive chemical composition and potential health benefits, but notes the lack of human trial evidence and the need for better testing methods to ensure consistent quality and efficacy.
June 2026 in “Disease Models & Mechanisms” This editorial introduces a special issue on "In Vitro Models of Human Disease" in DMM, highlighting how these models enhance understanding of disease mechanisms, accelerate drug development, and support personalized treatment strategies.
June 2026 in “British Journal of Dermatology” In this real-world study, 27% of alopecia areata patients treated with ritlecitinib achieved a target SALT score, a result consistent with clinical trial findings, highlighting the value of patient-reported outcomes in understanding treatment impact beyond traditional measures.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study highlights Clitoria ternatea's potential in modern health and skincare, noting its antioxidant, antimicrobial, and anti-inflammatory properties observed in lab tests and exploring its uses in beauty products, yet emphasizes the need for human trials to confirm benefits and ensure quality.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, Clitoria ternatea Linn., a plant from the pea family, is noted for potential health benefits, including antioxidant, antimicrobial, and anti-inflammatory effects, though human trial evidence is lacking and research on consistent quality is needed for practical applications.
May 2026 in “Scientific and Technical Bulletin оf State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives аnd Institute of Animal Biology” The researchers reported that zinc carbonate nanoparticles stabilized with polyvinylpyrrolidone did not show local irritant or skin-resorptive effects in preclinical tests on rabbits and rats.
This study developed a natural hair dye using Coreopsis tinctoria Nutt. extract, finding that it produced yellow to dark brown colors depending on the treatment, with ferrous lactate enhancing dye performance and color stability after washing.
April 2026 in “Psychiatry Neurology and Medical Psychology” This study found that women with mixed alopecia exhibited significantly higher levels of depression, anxiety, and stress compared to those with metabolic alopecia, with these emotional disturbances closely linked to heightened mental maladaptation.
April 2026 in “Actas Dermo-Sifiliográficas” This study reports that scalp cooling therapies and minoxidil may promote hair regrowth in patients experiencing persistent chemotherapy-induced alopecia, with trichoscopy aiding in treatment assessment.
March 2026 in “American Journal of Clinical Dermatology” This narrative review provides an overview of the persistent dermatological side effects experienced by cancer survivors due to treatments, highlighting their impact on quality of life and the need for structured dermatological care during survivorship.
March 2026 in “Journal of Veterinary and Animal Sciences” This study found that pre-ruminant crossbred calves supplemented with sodium butyrate had significantly lower alopecia scores compared to those receiving a probiotic and emulsifier, though both groups experienced alopecia between the 2nd and 6th weeks.
March 2026 in “Cosmetics” This observational study found that endoscopic subcutaneous midface elevation with vertical SMAS plication safely and effectively rejuvenates the mid and lower face in patients under 45 with early facial soft-tissue ptosis, reporting no facial nerve injuries and minor complications like localized cicatricial alopecia and hematomas.
March 2026 in “Preprints.org” This review of robotic systems in aesthetic plastic surgery found they offer precision and minimally invasive access, but their adoption is limited by high costs and technological limitations; further research is needed for standardization and wider application.
This study introduced a deep learning framework combining multiple convolutional neural networks to detect scalp and hair disorders and classify hair fall stages, reporting higher precision and robustness in detection and classification compared to individual CNN models.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study evaluated a herbal hair serum, finding it effective against certain fungi and bacteria and showing potential for hair regrowth comparable to standard treatments, suggesting it may serve as a natural alternative for promoting hair health.
This case-control study found no significant link between androgenic alopecia or hypertrichosis and prostate cancer in Dravidian men from Tamil Nadu, suggesting different prostate cancer risk factors compared to Western populations.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, a newly formulated herbal hair serum demonstrated significant antifungal and antibacterial activity as well as comparable hair regrowth effectiveness to standard treatments, suggesting its potential as a natural therapeutic alternative.
February 2026 in “Scientific Messenger of LNU of Veterinary Medicine and Biotechnology” This review discusses the diagnosis and treatment of dermatophytosis in cats, highlighting the susceptibility of Persian and young cats and the use of antifungal agents and new therapies.
February 2026 in “International Journal of Science and Research (IJSR)” This case report describes an 18-year-old female with alopecia areata who experienced hair regrowth within seven days following Prachana Vidhi treatment in an Ayurvedic setting, suggesting this approach may offer effective results for patchy hair loss.
February 2026 in “International Journal of Science and Research (IJSR)” In this prospective observational study, researchers found that androgenetic alopecia was the most common hair disorder among patients at a South Indian tertiary care center, predominantly affecting males, while telogen effluvium showed significant improvement after 3 months, highlighting stress as a key modifiable risk factor.
February 2026 in “Oncology Reviews” This review highlights the promising clinical outcomes of sacituzumab tirumotecan (sac-TMT), an antibody-drug conjugate for breast cancer that targets TROP2, demonstrating improved response rates and progression-free survival, with manageable safety concerns including primarily mild-to-moderate nausea and alopecia.
February 2026 in “The Journal of Sexual Medicine” In this case report, goserelin, a GnRH agonist, was effective in managing stuttering priapism and improving erectile function in a patient with sickle cell disease, suggesting potential for last-line treatment.
January 2026 in “EJC Skin Cancer” This research underscores the significant challenge of managing hair loss after cancer treatment and explores the need to evaluate new topical strategies to promote faster and higher-quality hair regrowth, as existing recovery processes are often slow and sometimes incomplete.
January 2026 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” This study developed a deep-learning model that accurately diagnosed alopecia areata with an accuracy of 88.92% and distinguished its activity levels with an accuracy of 83.33%, highlighting the potential for artificial intelligence in improving the diagnosis and treatment of this autoimmune hair loss condition.
January 2026 in “Avicenna Bulletin” In this study, male patients with stage III-IV androgenetic alopecia who underwent hair transplantation using a technique that considers the direction and angle of hair growth reported a 19.7% increase in satisfaction regarding the naturalness of their results.
January 2026 in “Современные проблемы науки и образования (Modern Problems of Science and Education)” 308 nm excimer phototherapy can help some people with alopecia areata regrow hair, especially if their condition is less severe.
December 2025 in “Голова и шея.” In this study conducted at a Russian military hospital, the researchers found that using a (bi)eyebrow surgical approach with endonasal video navigation significantly reduced postoperative complications, such as skin sensitivity impairment and visible scarring, compared to the open bicoronal approach for treating frontal sinus injuries.
December 2025 in “Russian Journal of Skin and Venereal Diseases” This study found that in patients with non-cicatricial alopecia, hair follicles and their sheaths were thinner compared to controls, especially in cases of alopecia areata and telogen effluvium, with notable thinning beginning in the subcutaneous fat tissue.
December 2025 in “Reports of Morphology” This study found that young adult Ukrainian men with alopecia areata had significantly different skinfold thickness at several body sites compared to healthy peers, suggesting unique patterns of fat distribution associated with the disease.